MIS Interbody Devices Market Analysis | United States | 2019-2025 | MedCore
- Year: 2017
- Scope: 2013-2023
- Region: United States
- Pages: 476
- Published Date: 5/1/2017
- Type: MedCore
The OLIF segment is the newest segment in the minimally invasive interbody device market but has experienced high growth. Despite its low growth, the MITLIF market share of the total market will remain relatively unchanged. Declining ASPs experienced in each segment will moderate market growth. LLIF procedures, however, are expected to experience the largest ASP decline.
Interbody (IB) devices are designed to replace the intervertebral discs of the spine; this enhances stability in the region and promotes fusion between the two vertebral bodies. These devices are threaded, allowing them to be used in conjunction with bone graft material. Over time, the packed graft is gradually replaced by natural bone, forming a solid piece.
Segments Covered in This Market
- MIPLIF Market
- MITLIF Market
- LLIF Market
- OLIF Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
NuVasive was the leading competitor in the total MIS interbody fusion market in 2016 due to its strong lead in the LLIF segment. Medtronics presence in the LLIF market is supported by the Direct Lateral Interbody Fusion (DLIF®) procedure. Globus Medical also has the InterContinental®, which is designed to ensure optimal endplate contact while matching different patient anatomy. Other companies analyzed include DePuy Synthes, Stryker, K2M, Zimmer Biomet and RTI Surgical.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled U.S. Market Report Suite for Minimally Invasive Spinal Implants – MedSuite
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
MIS Interbody Devices Market Analysis | United States | 2019-2025 | MedCore
$295 – $5,995
Interbody (IB) devices are designed to replace the intervertebral discs of the spine; this enhances stability in the region and promotes fusion between the two vertebral bodies. These devices are threaded, allowing them to be used in conjunction with bone graft material. Over time, the packed graft is gradually replaced by natural bone, forming a solid piece. IB fusion procedures typically add a posterior fixation device to the associated level. These procedures are often referred to as 360° fusions, as surgeons will implant interbody devices from an anterior approach and flip the patient over to implant a posterior pedicle screw device. This combination increases the fusion success rate over standalone interbody fusion device implantation without the addition of fixation devices.
- 2017
- 2013-2023
- United States
- 5/1/2017
- 476
- MedCore
Related Reports
